caffeine has been researched along with Cardiac Hypertrophy in 28 studies
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Excerpt | Relevance | Reference |
---|---|---|
"Intermittent exposure to CPF induced cardiac hypertrophy, increasing cardiomyocyte diameter and collagen content." | 5.72 | Intermittent exposure to chlorpyrifos results in cardiac hypertrophy and oxidative stress in rats. ( Aitken, AV; Batista, TJ; Beijamini, V; Bissoli, NS; Coitinho, JB; de Sousa, GJ; Gonçalves, RCR; Hott, SC; Minassa, VS; Paton, JFR; Sampaio, KN, 2022) |
"Compensated cardiac hypertrophy was induced by abdominal aortic constriction for 5 wk followed by administration of ramipril (50 microg x kg(-1) x day(-1)) or vehicle for 4 wk." | 5.31 | Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy. ( Boateng, SY; Boheler, KR; Koban, MU; MacLeod, KT; Naqvi, RU; Yacoub, MH, 2001) |
"This study aimed to quantify the effect of cardiac hypertrophy induced with isoprenaline and caffeine on reflex regulation of renal sympathetic nerve activity by the arterial and cardiopulmonary baroreceptors." | 3.74 | Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats. ( Aherne, CM; Buckley, MM; Flanagan, ET; Johns, EJ; Lainis, F; Sattar, M, 2008) |
"Intermittent exposure to CPF induced cardiac hypertrophy, increasing cardiomyocyte diameter and collagen content." | 1.72 | Intermittent exposure to chlorpyrifos results in cardiac hypertrophy and oxidative stress in rats. ( Aitken, AV; Batista, TJ; Beijamini, V; Bissoli, NS; Coitinho, JB; de Sousa, GJ; Gonçalves, RCR; Hott, SC; Minassa, VS; Paton, JFR; Sampaio, KN, 2022) |
"Compensated cardiac hypertrophy was induced by abdominal aortic constriction for 5 wk followed by administration of ramipril (50 microg x kg(-1) x day(-1)) or vehicle for 4 wk." | 1.31 | Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy. ( Boateng, SY; Boheler, KR; Koban, MU; MacLeod, KT; Naqvi, RU; Yacoub, MH, 2001) |
"Thus, in spite of the modest cardiac hypertrophy, the overexpressed LCCs form functional coupling with RyRs, preserving both orthograde and retrograde Ca(2+) signaling between LCCs and RyRs." | 1.31 | Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel. ( Cheng, H; Guia, A; Josephson, IR; Lakatta, EG; Muth, JN; Rubio, M; Schwartz, A; Song, LS; Wang, SQ; Xiao, RP, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (10.71) | 18.7374 |
1990's | 8 (28.57) | 18.2507 |
2000's | 11 (39.29) | 29.6817 |
2010's | 5 (17.86) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Minassa, VS | 1 |
Aitken, AV | 1 |
Hott, SC | 1 |
de Sousa, GJ | 1 |
Batista, TJ | 1 |
Gonçalves, RCR | 1 |
Coitinho, JB | 1 |
Paton, JFR | 1 |
Beijamini, V | 1 |
Bissoli, NS | 1 |
Sampaio, KN | 1 |
Zhong, X | 1 |
Vallmitjana, A | 1 |
Sun, B | 1 |
Xiao, Z | 1 |
Guo, W | 1 |
Wei, J | 1 |
Ni, M | 1 |
Chen, Y | 1 |
O'Brien, ER | 1 |
Gillis, AM | 1 |
Hoshijima, M | 1 |
Takeshima, H | 1 |
Hove-Madsen, L | 1 |
Benitez, R | 1 |
Belke, D | 1 |
Wayne Chen, SR | 1 |
Landstrom, AP | 1 |
Kellen, CA | 1 |
Dixit, SS | 1 |
van Oort, RJ | 1 |
Garbino, A | 1 |
Weisleder, N | 1 |
Ma, J | 1 |
Wehrens, XH | 1 |
Ackerman, MJ | 1 |
Hulot, JS | 1 |
Fauconnier, J | 1 |
Ramanujam, D | 1 |
Chaanine, A | 1 |
Aubart, F | 1 |
Sassi, Y | 1 |
Merkle, S | 1 |
Cazorla, O | 1 |
Ouillé, A | 1 |
Dupuis, M | 1 |
Hadri, L | 1 |
Jeong, D | 1 |
Mühlstedt, S | 1 |
Schmitt, J | 1 |
Braun, A | 1 |
Bénard, L | 1 |
Saliba, Y | 1 |
Laggerbauer, B | 1 |
Nieswandt, B | 1 |
Lacampagne, A | 1 |
Hajjar, RJ | 2 |
Lompré, AM | 1 |
Engelhardt, S | 1 |
Buckley, MM | 2 |
Johns, EJ | 2 |
Ruiz-Hurtado, G | 1 |
Domínguez-Rodríguez, A | 1 |
Pereira, L | 1 |
Fernández-Velasco, M | 1 |
Cassan, C | 1 |
Lezoualc'h, F | 1 |
Benitah, JP | 1 |
Gómez, AM | 1 |
Kirchhefer, U | 2 |
Baba, HA | 2 |
Kobayashi, YM | 2 |
Jones, LR | 3 |
Schmitz, W | 2 |
Neumann, J | 2 |
Maier, LS | 1 |
Zhang, T | 1 |
Chen, L | 1 |
DeSantiago, J | 1 |
Brown, JH | 1 |
Bers, DM | 2 |
HEIMANN, W | 1 |
WILBRANDT, W | 1 |
Ng, GA | 1 |
Song, LJ | 1 |
Wang, GL | 1 |
Liu, J | 1 |
Qiu, QY | 1 |
Ou, JH | 1 |
Guan, YY | 1 |
Flanagan, ET | 1 |
Aherne, CM | 1 |
Lainis, F | 1 |
Sattar, M | 1 |
Aronson, RS | 1 |
Nordin, C | 1 |
Naqvi, RU | 2 |
Macleod, KT | 2 |
Tomita, F | 1 |
Bassett, AL | 2 |
Myerburg, RJ | 2 |
Kimura, S | 2 |
Suzuki, YJ | 1 |
Wang, W | 1 |
Ramesh, V | 1 |
Franzini-Armstrong, C | 1 |
Cleemann, L | 1 |
Morad, M | 1 |
Pogwizd, SM | 1 |
Qi, M | 1 |
Yuan, W | 1 |
Samarel, AM | 1 |
Linck, B | 1 |
Bokník, P | 1 |
Huke, S | 1 |
Knapp, J | 1 |
Lüss, H | 1 |
Müller, FU | 1 |
Tanriseven, Z | 1 |
Vahlensieck, U | 1 |
Philipson, KD | 1 |
Boateng, SY | 1 |
Koban, MU | 1 |
Yacoub, MH | 1 |
Boheler, KR | 1 |
Meyer, TE | 1 |
Chung, ES | 1 |
Perlini, S | 1 |
Norton, GR | 1 |
Woodiwiss, AJ | 1 |
Lorbar, M | 1 |
Fenton, RA | 1 |
Dobson, JG | 1 |
Kline, R | 1 |
Jiang, T | 1 |
Xu, X | 1 |
Rybin, VO | 1 |
Steinberg, SF | 1 |
Karvats'kiĭ, IM | 1 |
Lahodych, TS | 1 |
Shevchuk, VH | 1 |
Song, LS | 1 |
Guia, A | 1 |
Muth, JN | 1 |
Rubio, M | 1 |
Wang, SQ | 1 |
Xiao, RP | 1 |
Josephson, IR | 1 |
Lakatta, EG | 1 |
Schwartz, A | 1 |
Cheng, H | 1 |
Rooke, GA | 1 |
Su, JY | 1 |
Furukawa, T | 1 |
Furukawa, N | 1 |
Baudet, S | 1 |
Ventura-Clapier, R | 1 |
Gwathmey, JK | 1 |
Thollon, C | 1 |
Kreher, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry[NCT05158751] | 100 participants (Anticipated) | Observational | 2023-01-31 | Not yet recruiting | |||
Role of a Novel Implantable Loop Recorder in the Management of Premature Ventricular Contractions[NCT06060548] | 50 participants (Anticipated) | Observational | 2022-04-20 | Recruiting | |||
Risk Stratifications for Patients Come With Palpitations in Assiut and Suez Canal University Hospitals[NCT06103305] | 208 participants (Anticipated) | Observational | 2023-10-31 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for caffeine and Cardiac Hypertrophy
Article | Year |
---|---|
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
27 other studies available for caffeine and Cardiac Hypertrophy
Article | Year |
---|---|
Intermittent exposure to chlorpyrifos results in cardiac hypertrophy and oxidative stress in rats.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Caffeine; Cardiomegaly; Chlorpyrifos; Humans; | 2022 |
Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Signaling; Cardiomegaly; Death, Sudden, Cardi | 2018 |
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.
Topics: Animals; Caffeine; Calcium Channels, L-Type; Calcium Signaling; Cardiomegaly; Cardiomyopathy, Hypert | 2011 |
Critical role for stromal interaction molecule 1 in cardiac hypertrophy.
Topics: Adenoviridae; Age Factors; Animals; Animals, Newborn; Caffeine; Calcium; Calcium Channels; Calcium S | 2011 |
Impact of L-NAME on the cardiopulmonary reflex in cardiac hypertrophy.
Topics: Animals; Baroreflex; Blood Pressure; Blood Volume; Caffeine; Cardiomegaly; Disease Models, Animal; D | 2011 |
Sustained Epac activation induces calmodulin dependent positive inotropic effect in adult cardiomyocytes.
Topics: Animals; Caffeine; Calcium Channels, L-Type; Calcium Signaling; Calmodulin; Cardiomegaly; Cells, Cul | 2012 |
Altered function in atrium of transgenic mice overexpressing triadin 1.
Topics: Age Factors; Animals; Atrial Function; Caffeine; Calcium; Calcium-Binding Proteins; Calcium-Transpor | 2002 |
Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release.
Topics: Animals; Benzylamines; Blotting, Western; Caffeine; Calcium; Calcium Channels; Calcium-Binding Prote | 2003 |
[Studies on coronary-dilatating effects on Langendorff's preparation and its interpretation on the basis of competitive antagonism].
Topics: Caffeine; Cardiomegaly; Heart; Humans; Khellin; Papaverine; Theophylline | 1954 |
Cellular mechanisms of reduced sarcoplasmic reticulum Ca2+ content in L-thyroxin induced rat ventricular hypertrophy.
Topics: Animals; Caffeine; Calcium; Cardiomegaly; Electrocardiography; Heart Ventricles; Hypertrophy, Left V | 2008 |
Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
Topics: Animals; Baroreflex; Blood Pressure; Body Weight; Caffeine; Cardiomegaly; Central Nervous System Sti | 2008 |
Electrophysiologic properties of hypertrophied myocytes isolated from rats with renal hypertension.
Topics: Action Potentials; Animals; Caffeine; Calcium; Cardiomegaly; Cells, Cultured; Electric Conductivity; | 1984 |
Effect of hypertrophy on mechanisms of relaxation in isolated cardiac myocytes from guinea pig.
Topics: Animals; Caffeine; Calcium; Calcium-Transporting ATPases; Cardiomegaly; Cells, Cultured; Fluorescent | 1994 |
Diminished effect of cAMP on Ca2+ accumulation in skinned fibers of hypertrophied rat heart.
Topics: Animals; Biological Transport; Caffeine; Calcium; Cardiomegaly; Cyclic AMP; Dose-Response Relationsh | 1994 |
Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Calcium-Binding Proteins; Calsequestrin; Cardiomegaly; | 1998 |
Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure.
Topics: Animals; Aortic Valve Insufficiency; Arrhythmias, Cardiac; Caffeine; Calcium; Cardiomegaly; Constric | 1999 |
Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.
Topics: Animals; Body Weight; Caffeine; Calcium; Calcium Channels, L-Type; Calcium-Transporting ATPases; Cal | 2000 |
Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy.
Topics: Animals; Antihypertensive Agents; Caffeine; Calcium; Calcium-Transporting ATPases; Cardiomegaly; Dos | 2001 |
Antiadrenergic effects of adenosine in pressure overload hypertrophy.
Topics: Adenosine; Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; C | 2001 |
Abnormal calcium and protein kinase C-epsilon signaling in hypertrophied atrial tumor myocytes (AT-1 cells).
Topics: Animals; Caffeine; Calcium Signaling; Calcium-Transporting ATPases; Cardiomegaly; Cell Differentiati | 2001 |
[Effect of nitric oxide on force-frequency relations in experimental hyperfunction and hypertrophy in the heart muscle].
Topics: Action Potentials; Animals; Arginine; Caffeine; Cardiomegaly; Dose-Response Relationship, Drug; Elec | 2001 |
Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel.
Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Channels, L-Type; Calcium Signaling; Calcium- | 2002 |
Left ventricular hypertrophy in rabbits does not exaggerate the effects of halothane on the intracellular components of cardiac contraction.
Topics: Animals; Body Weight; Caffeine; Calcium; Cardiomegaly; Halothane; Male; Myocardial Contraction; Orga | 1992 |
Effect of acidosis on contractile system in skinned fibers of hypertrophied rat heart.
Topics: Acidosis; Animals; Caffeine; Calcium; Cardiomegaly; Heart; Histological Techniques; Hydrogen-Ion Con | 1990 |
Differential effects of caffeine on skinned fibers from control and hypertrophied ferret hearts.
Topics: Animals; Caffeine; Calcium; Cardiomegaly; Ferrets; Heart Ventricles; Histological Techniques; Male; | 1990 |
Intracellular calcium related to force development in twitch contraction of mammalian myocardium.
Topics: Actin Cytoskeleton; Aequorin; Animals; Caffeine; Calcium; Cardiomegaly; Ferrets; Hyperthyroidism; Is | 1990 |
Altered electrical response to caffeine exposure in hypertrophied rat myocardium.
Topics: Action Potentials; Animals; Caffeine; Cardiomegaly; Coronary Vessels; Electrophysiology; Female; Iso | 1989 |